NCT07217470 is a clinical trial in ESRD (End Stage Renal Disease), sponsored by HemoCept Inc..

Who is sponsoring NCT07217470?

NCT07217470 is sponsored by HemoCept Inc..

What condition does NCT07217470 study?

NCT07217470 studies ESRD (End Stage Renal Disease).

Is NCT07217470 still recruiting?

NCT07217470 is currently completed. Last updated 2 December 2025.

Last reviewed 2025-12-02 · How we verify

NCT07217470

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fluid Status of ESRD Patients Undergoing Dialysis

Completed Last updated 2 December 2025

What this trial tests

trial in ESRD (End Stage Renal Disease) in 26 participants. Completed in 20 November 2025.

Timeline

18 August 2025

Primary endpoint
20 November 2025

20 November 2025

Quick facts

Lead sponsor	HemoCept Inc.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	26
Start date	18 August 2025
Primary completion	20 November 2025
Estimated completion	20 November 2025
Sites	1 location across United States

Conditions studied

ESRD (End Stage Renal Disease) — all drugs for ESRD (End Stage Renal Disease) →

Sponsor

HemoCept Inc.

Who can join

Adults 18 to 75, any sex, with ESRD (End Stage Renal Disease). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The pilot clinical study will assess the correlation between fluid removal during dialysis and HemoCept device data.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other HemoCept Inc. trials

Trials by the same sponsor.

NCT07217041 — Fluid Status of Dialysis Subjects · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07217470 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by HemoCept Inc.
Last refreshed: 2 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07217470.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing